Synthesized Polymers-Functionalized PEG
Synthesized Polymers-Functionalized PEG
Seebio Biotech, Inc. provides a variety of Synthesized Polymers such as Functionalized Polystyrene (PS), Functionalized Polyisoprene (PI), Functionalized Polyvinylpyridine ,block Copolymer(33) and so on.
Please contact us for more natural or synthesized polymers.
Product Detail:
1. Functionalized PEG (262)
No.
Description
Structure
1
mPEO-OH
2
mPEO-COOH
3
mPEO-COOH
4
mPEO-COOH
5
mPEO-SC
6
mPEO-SCM
7
mPEO-SPA
8
mPEO-SS
9
mPEO-ALD
10
mPEO-ALD
11
mPEO-ALD
12
mPEO-NH2
13
mPEO-NH2
14
mPEO-MAL
15
mPEO-MAL
16
mPEO-SH
17
mPEO- Propargyl
18
mPEO-Allyl
19
mPEO- Acryloyl
20
mPEO-Br
21
mPEO-TEMPO
22
mPEO-OTS
23
mPEO-N3
Parameters:
Molecular Weight Range, 500-500,000Da
PDI, ≤1.08
Package: 1mg-5000g
1.1 Monofunctional PEG(23)
1.2 Bifunctional PEG (23)
|
No. |
Description |
Structure |
|
1 |
HO-PEG-OH |
|
|
2 |
HOOC-PEG-COOH |
|
|
3 |
HOOC-PEG-COOH |
|
|
4 |
HOOC-PEG-COOH |
|
|
5 |
SC-PEG-SC |
|
|
6 |
SCM-PEG-SCM |
|
|
7 |
SPA-PEG-SPA |
|
|
8 |
SS-PEG-SS |
|
|
9 |
ALD-PEG-ALD |
|
|
10 |
ALD-PEG-ALD |
|
|
11 |
ALD-PEG-ALD |
|
|
12 |
NH2-PEG-NH2 |
|
|
13 |
NH2-PEG-NH2 |
|
|
14 |
MAL-PEG-MAL |
|
|
15 |
MAL-PEG-MAL |
|
|
16 |
HS-PEG-SH |
|
|
17 |
Propargyl-PEG-Propargyl |
|
|
18 |
Allyl -PEG-Allyl |
|
|
19 |
Acryloyl-PEG-Acryloyl |
|
|
20 |
Br-PEG-Br |
|
|
21 |
TEMPO-PEG-TEMPO |
|
|
22 |
OTS-PEG-OTS |
|
|
23 |
N3-PEG- N3 |
|
1.3 Heterofunctional PEG (69)
|
No. |
Description |
Structure |
|
1 |
HO-PEG-COOH |
|
|
2 |
HO-PEG- COOH |
|
|
3 |
HO-PEG- ALD |
|
|
4 |
HO-PEG- ALD |
|
|
5 |
HO-PEG- ALD |
|
|
6 |
HO-PEG- NH2 |
|
|
7 |
HO-PEG- MAL |
|
|
8 |
HO-PEG- SH |
|
|
9 |
HO-PEG- Propargyl |
|
|
10 |
HO-PEG- Allyl |
|
|
11 |
HO-PEG- TEMPO |
|
|
12 |
ALD-PEG- COOH |
|
|
13 |
ALD-PEG- COOH |
|
|
14 |
ALD-PEG- SH |
|
|
15 |
ALD-PEG- Propargyl |
|
|
16 |
ALD-PEG- Allyl |
|
|
17 |
ALD-PEG- TEMPO |
|
|
18 |
ALD-PEG- COOH |
|
|
19 |
ALD-PEG- COOH |
|
|
20 |
ALD-PEG- SH |
|
|
21 |
ALD-PEG- Propargyl |
|
|
22 |
ALD-PEG- Allyl |
|
|
23 |
ALD-PEG- TEMPO |
|
|
24 |
ALD-PEG- COOH |
|
|
25 |
ALD-PEG- COOH |
|
|
26 |
ALD-PEG-SH |
|
|
27 |
ALD-PEG- Propargyl |
|
|
28 |
ALD-PEG- Allyl |
|
|
29 |
ALD-PEG-TEMPO |
|
|
30 |
TEMPO-PEG-OH |
|
|
31 |
TEMPO-PEG-COOH |
|
|
32 |
TEMPO-PEG-COOH |
|
|
33 |
TEMPO-PEG-COOH |
|
|
34 |
TEMPO-PEG-SC |
|
|
35 |
TEMPO-PEG-SCM |
|
|
36 |
TEMPO-PEG-SPA |
|
|
37 |
TEMPO-PEG-SS |
|
|
38 |
TEMPO-PEG-ALD |
|
|
39 |
TEMPO-PEG-ALD |
|
|
40 |
TEMPO-PEG-ALD |
|
|
41 |
TEMPO-PEG-SH |
|
|
42 |
TEMPO-PEG-Propargyl |
|
|
43 |
TEMPO-PEG-Allyl |
|
|
44 |
TEMPO-PEG- Acryloyl |
|
|
45 |
TEMPO-PEG- Br |
|
|
46 |
TEMPO-PEG- OTs |
|
|
47 |
TEMPO-PEG- N3 |
|
|
48 |
Allyl-PEG-COOH |
|
|
49 |
Allyl-PEG-COOH |
|
|
50 |
Allyl-PEG-COOH |
|
|
51 |
Allyl-PEG-SC |
|
|
52 |
Allyl-PEG-SCM |
|
|
53 |
Allyl-PEG-SPA |
|
|
54 |
Allyl-PEG-SS |
|
|
55 |
Allyl-PEG-ALD |
|
|
56 |
Allyl-PEG-ALD |
|
|
57 |
Allyl-PEG-ALD |
|
|
58 |
Allyl-PEG- SH |
|
|
59 |
Allyl-PEG-Propargyl |
|
|
60 |
Allyl-PEG- Acryloyl |
|
|
61 |
Allyl-PEG-Br |
|
|
62 |
Allyl-PEG-OTs |
|
|
63 |
Allyl-PEG-N3 |
|
|
64 |
HOOC-PEG-OH |
|
|
65 |
HOOC-PEG-OH |
|
|
66 |
NH2-PEG-OH |
|
|
67 |
NH2-PEG-COOH |
|
|
68 |
NH2-PEG-OH |
|
|
69 |
NH2-PEG-COOH |
|
1.4 2-Armed V-shaped PEG (45)
|
No. |
Description |
Structure |
|
1 |
(HOOC-PEO)2-OH |
|
|
2 |
(HOOC-PEO)2-OH |
|
|
3 |
(ALD-PEO)2-OH |
|
|
4 |
(ALD-PEO)2-OH |
|
|
5 |
(ALD-PEO)2-OH |
|
|
6 |
(Propargyl-PEO)2-OH |
|
|
7 |
(Allyl-PEO)2-OH |
|
|
8 |
(TEMPO-PEO)2-OH |
|
|
9 |
(mPEO)2-OH |
|
|
10 |
(mPEO)2-COOH |
|
|
11 |
(mPEO)2-COOH |
|
|
12 |
(mPEO)2-COOH |
|
|
13 |
(mPEO)2-SC |
|
|
14 |
(mPEO)2-SCM |
|
|
15 |
(mPEO)2-SPA |
|
|
16 |
(mPEO)2-SS |
|
|
17 |
(mPEO)2-ALD |
|
|
18 |
(mPEO)2- ALD |
|
|
19 |
(mPEO)2- ALD |
|
|
20 |
(mPEO)2-NH2 |
|
|
21 |
(mPEO)2- NH2 |
|
|
22 |
(mPEO)2-MAL |
|
|
23 |
(mPEO) 2-MAL |
|
|
24 |
(mPEO)2-SH |
|
|
25 |
(mPEO)2-Propargyl |
|
|
26 |
(mPEO)2-Allyl |
|
|
27 |
(mPEO)2- Acryloyl |
|
|
28 |
(mPEO)2-Br |
|
|
29 |
(mPEO)2-TEMOPO |
|
|
30 |
(mPEO)2-Ts |
|
|
31 |
(mPEO)2-N3 |
|
|
32 |
(HOOC-PEO)2-Allyl |
|
|
33 |
(HOOC-PEO)2-Allyl |
|
|
34 |
(Propargyl-PEO)2-Allyl |
|
|
35 |
(HO-PEO)2-COOH |
|
|
36 |
(HO-PEO)2-COOH |
|
|
37 |
(HO-PEO)2-NH2 |
|
|
38 |
(HOOC-PEO)2- NH2 |
|
|
39 |
(HOOC-PEO)2- NH2 |
|
|
40 |
(HOOC-PEO)2-OH |
|
|
41 |
(HOOC-PEO)2-OH |
|
|
42 |
(mPEO)2-COOH |
|
|
43 |
(mPEO)2-COOH |
|
|
44 |
(mPEO)2-NH2 |
|
|
45 |
(mPEO)2-OH |
|
1.5 3-Armed Y-shaped PEG (15)
|
No. |
Description |
Structure |
|
1 |
(mPEO)2-(PEO-OH) |
|
|
2 |
(mPEO)2-(PEO-COOH) |
|
|
3 |
(mPEO) 2-(PEO-SC) |
|
|
4 |
(mPEO) 2-(PEO-SPA) |
|
|
5 |
(mPEO) 2-(PEO-MAL) |
|
|
6 |
(mPEO)2-(PEO-ALD) |
|
|
7 |
(mPEO)2-(PEO-NH2) |
|
|
8 |
(mPEO) 2-(PEO-SH) |
|
|
9 |
(mPEO) 2-(PEO-Propargyl) |
|
|
10 |
(mPEO)2-(PEO-Allyl) |
|
|
11 |
(mPEO)2- (PEO-Acryloyl) |
|
|
12 |
(mPEO) 2- (PEO-Br) |
|
|
13 |
(mPEO)2- (PEO-TEMPO) |
|
|
14 |
(mPEO)2- (PEO-Ts) |
|
|
15 |
(mPEO) 2- (PEO-N3) |
|
1.6 3-Armed V-shaped PEG (15)
|
No. |
Description |
Structure |
|
1 |
(mPEO)3-OH 3-(PEO-OH) |
|
|
2 |
(mPEO)3-COOH 3-(PEO-COOH) |
|
|
3 |
(mPEO)3-SC3-(PEO-SC) |
|
|
4 |
(mPEO)3-SPA(mPEO)3-(PEO-SPA) |
|
|
5 |
(mPEO)3-MAL3-(PEO-MAL) |
|
|
6 |
(mPEO)3-ALD 3-(PEO-ALD) |
|
|
7 |
(mPEO)3-NH23-(PEO-NH2) |
|
|
8 |
(mPEO)3-SH3-(PEO-SH) |
|
|
9 |
(mPEO)3-Propargyl3-(PEO-Propargyl) |
|
|
10 |
(mPEO)3-Allyl3-(PEO-Allyl) |
|
|
11 |
(mPEO)3-Acryloyl- (PEO-Acryloyl) 3 |
|
|
12 |
(mPEO)3-Br3- (PEO-Br) |
|
|
13 |
(mPEO)3-TEMPO3- (PEO-TEMPO) |
|
|
14 |
(mPEO)3-Ts 3- (PEO-Ts)(mPEO)3-N3 |
|
|
15 |
(mPEO)3- (PEO-N 3) |
|
1.7 4-Armed Y-shaped PEG (15)
|
No. |
Description |
Structure |
|
1 |
(mPEO)3-(PEO-OH)2-(PEO-OH) |
|
|
2 |
(mPEO)3-(PEO-COOH)2-(PEO-COOH) |
|
|
3 |
(mPEO)3-(PEO-SC) 2-(PEO-SC) |
|
|
4 |
(mPEO)3-(PEO-SPA) 2-(PEO-SPA) |
|
|
5 |
(mPEO)3-(PEO-MAL)(mPEO)2-(PEO-MAL) |
|
|
6 |
(mPEO)3-(PEO-ALD)2-(PEO-ALD) |
|
|
7 |
(mPEO)3-(PEO-NH2) 2-(PEO-NH2) |
|
|
8 |
(mPEO)3-(PEO-SH)2-(PEO-SH) |
|
|
9 |
(mPEO)3-(PEO-2-(PEO-Propargyl Propargyl)) |
|
|
10 |
(mPEO)3-(PEO-Allyl) 2-(PEO-Allyl) |
|
|
11 |
(mPEO)3-(PEO-Acryloyl)2- (PEO-Acryloyl) |
|
|
12 |
(mPEO)3-(PEO-Br) 2- (PEO-Br) |
|
|
13 |
(mPEO)3-(PEO-TEMPO)2- (PEO-TEMPO) |
|
|
14 |
(mPEO)3-(PEO-Ts)(mPEO) 2- (PEO-Ts) |
|
|
15 |
(mPEO)3-(PEO-N3) 2- (PEO-N3) |
|
1.8 Dendrimer-like PEG (30)
|
No. |
Description |
Structure |
|
1 |
(mPEO) 4-(PEO)2-OH |
|
|
2 |
(mPEO) 4-(PEO)2-COOH |
|
|
3 |
(mPEO) 4-(PEO)2-SC |
|
|
4 |
(mPEO) 4-(PEO)2-SPA |
|
|
5 |
(mPEO) 4-(PEO)2-MAL |
|
|
6 |
(mPEO) 4-(PEO)2-ALD |
|
|
7 |
(mPEO) 4-(PEO)2-NH2 |
|
|
8 |
(mPEO) 4-(PEO)2-SH |
|
|
9 |
((mPEO) 4-(PEO)2-Propargyl |
|
|
10 |
(mPEO) 4-(PEO)2-Allyl |
|
|
11 |
(mPEO) 4-(PEO)2-Acryloyl |
|
|
12 |
(mPEO) 4-(PEO)2-Br |
|
|
13 |
(mPEO) 4-(PEO)2-TEMPO |
|
|
14 |
(mPEO) 4-(PEO)2-Ts |
|
|
15 |
(mPEO) 4-(PEO)2-N3 |
|
|
16 |
(mPEO) 4-(PEO)2-PEO-OH |
|
|
17 |
(mPEO) 4-(PEO)2-PEO-COOH |
|
|
18 |
(mPEO) 4-(PEO)2- PEO-SC |
|
|
19 |
(mPEO) 4-(PEO)2- PEO-SPA |
|
|
20 |
(mPEO) 4-(PEO)2-PEO-MAL |
|
|
21 |
(mPEO) 4-(PEO)2-PEO-ALD |
|
|
22 |
(mPEO) 4-(PEO)2- PEO-NH2 |
|
|
23 |
(mPEO) 4-(PEO)2- PEO-SH |
|
|
24 |
((mPEO)4-(PEO)2-PEO-Propargyl |
|
|
25 |
(mPEO) 4-(PEO)2-PEO-Allyl |
|
|
26 |
(mPEO) 4-(PEO)2-PEO-Acryloyl |
|
|
27 |
(mPEO) 4-(PEO)2- PEO-Br |
|
|
28 |
(mPEO) 4-(PEO)2-PEO-TEMPO |
|
|
29 |
(mPEO) 4-(PEO)2- PEO-Ts |
|
|
30 |
(mPEO) 4-(PEO)2- PEO-N3 |
|
1.9 3-Armed PEG (9)
|
No. |
Description |
Structure |
|
1 |
3Arm (PEO-OH) 3 |
|
|
2 |
3Arm (PEO-COOH)3 |
|
|
3 |
3Arm (PEO-SH)3 |
|
|
4 |
3Arm (PEO-NH2)3 |
|
|
5 |
3Arm (PEO-Propargyl) 3 |
|
|
6 |
3Arm (PEO- Allyl3 |
|
|
7 |
3Arm (PEO- Acryloyl )3 |
|
|
8 |
3Arm (PEO-Br )3 |
|
|
9 |
3Arm (PEO- N 3)3 |
|
1.10 4-Armed PEG (9)
|
No. |
Description |
Structure |
|
1 |
4Arm (PEO-OH)4 |
|
|
2 |
4Arm (PEO-COOH)4 |
|
|
3 |
4Arm (PEO-NH2)4 |
|
|
4 |
4Arm (PEO-SH)4 |
|
|
5 |
4Arm (PEO-Propargyl)4 |
|
|
6 |
4Arm (PEO- Allyl)4 |
|
|
7 |
4Arm (PEO- Acryloyl )4 |
|
|
8 |
4Arm (PEO-Br )4 |
|
|
9 |
4Arm (PEO- N3)4 |
|
1.11 6-Armed PEG (9)
|
No. |
Description |
Structure |
|
1 |
6Arm (PEO-OH) 6 |
|
|
2 |
6Arm (PEO-COOH) 6 |
|
|
3 |
6Arm (PEO-SH) 6 |
|
|
4 |
6Arm (PEO- NH 2)6 |
|
|
5 |
6Arm (PEO-Propargyl) 6 |
|
|
6 |
6Arm (PEO- Acryloyl )6 |
|
|
7 |
6Arm (PEO- Allyl ) 6 |
|
|
8 |
6Arm (PEO- Br)6 |
|
|
9 |
6Arm (PEO-N 3)6 |
|
1. A variety of functional groups, good performance, high-purity,Mw 500-80,000, Polydispersity Index(PDI)less than 1.05;
2. The production process is simplified, low impurity n ice stability;
3. More than 400 various types, nearly 2,000 kinds of product;
4. Customized products and service.
1. Functionalized PEG (262)
1.1 Monofunctional PEG(23)
1.2 Bifunctional PEG (23)
1.3 Heterofunctional PEG (69)
1.4 2-Armed V-shaped PEG (45)
1.5 3-Armed Y-shaped PEG (15)
1.6 3-Armed V-shaped PEG (15)
1.7 4-Armed Y-shaped PEG (15)
1.8 Dendrimer-like PEG (30)
1.9 3-Armed PEG (9)
1.10 4-Armed PEG (9)
1.11 6-Armed PEG (9)
2. Funcationlaized Subsititued Poly(ether) (12)
3. Functionalized Polystyrene (PS) (36)
4. Functionalized Polyisoprene (PI)(20)
5. Functionalized Polyvinylpyridine (PVP) (36)
Please contact us for more natural or synthesized polymers.
Seebio Biotech, Inc.
11-502. Lane 299, Bisheng Rd.
Zhangjiang High Tech Park
Shanghai 201204, P.R.China
Tel: 86-21-50272975, 76, 77, 78, 79, 81,Ext:6513,6515,6516,6520,6521,6522
For customers' complaint or suggestion： 86-21-50272981-6821, 6818
Web： www.seebio.cn
Email：fyland@seebio.cn service@seebio.cn
MSN：seebio8@hotmail.com
Skype：seebiocn
 |
 |
 |
| 官網(wǎng)：www.baichuan365.com | 微信服務(wù)號：iseebio | 微博：seebiobiotech |
 |
 |
 |
| 商城：mall.seebio.cn | 微信訂閱號：seebiotech | 泉養(yǎng)堂：www.canmedo.com |
相關(guān)資訊
- Cell Rep：科學(xué)家揭示腸道菌群影響代謝疾病的新線索
- Science Immunology研究證實(shí)：鼻腔噴霧劑對阻止變異至關(guān)重要
- Science子刊：新型縱向研究記錄了在癥狀出現(xiàn)5個(gè)月后的COVID-19抗體反應(yīng)
- 早期腎損傷診斷用NAG底物
- 攻克阿爾茨海默癥的曙光！納米酶復(fù)合材料或可改善阿爾茨海默癥
- 瓊脂糖-鎳磁珠--純化和篩選組氨酸標(biāo)記的蛋白
- 快速了解這種甲級傳染病及其預(yù)防措施
- 2020年分子診斷市場有望達(dá)到93億美元
- Ludger高通量甲基化檢測方法
- 《Science》子刊：首次發(fā)現(xiàn)失眠是致命性腦動脈瘤破裂的潛在危險(xiǎn)因素
新進(jìn)產(chǎn)品
同類文章排行
- 膽堿酯酶檢測原料一覽
- 猴痘病毒檢測原料（涵蓋診斷酶、抗原、抗體），西寶生物助力猴痘檢測
- 西寶生物CHO細(xì)胞、HEK293細(xì)胞、 Vero細(xì)胞培養(yǎng)基產(chǎn)品
- 人和動物免疫球蛋白IgG全新上市
- 如何選擇合適的表面活性劑？
- 尿液分析試紙檢測原理及產(chǎn)品推薦
- 總膽紅素/直接膽紅素檢測一站式解決方案
- 分子診斷用酶原料一站式服務(wù)盡在西寶生物
- 體外診斷中交聯(lián)劑的用途與選擇
- 優(yōu)異的化妝品級水溶性β-1,3-葡聚糖
資訊文章
您的瀏覽歷史
